PETALING JAYA: LAC Med Bhd
has garnered strong interest for its initial public offering (IPO) on the Main Market of Bursa Malaysia, with the public tranche oversubscribed by 12.6 times.
In a statement, the medical devices and integrated solutions provider said it had received a total of 6,649 applications for approximately 272.8 million shares, amounting to approximately RM204.6mil, compared with the 20 million shares made available for application by the Malaysian public.
The IPO entails a total of approximately 104.2 million ordinary shares in LAC Med at an IPO price of RM0.75 per share.
Upon listing, the enlarged share capital of LAC Med will consist of 400 million shares, translating into an enlarged indicative market capitalisation of RM300mil.
Out of the total, approximately 74.2 million are new ordinary shares.
LAC Med is slated for listing on the Main Market of Bursa Malaysia on Dec 10, 2025.
